Skip to main content
  • Home
  • Advance Search
    • Customized Search
    • Biomarker search
    • Pathway Search
    • Target Sequence Similarity
    • Drug Structure Similarity
    • Coronavirus Search
  • Target Group
    • Successful Targets
    • Clinical Trial Targets
    • Drug Binding Sites of Target
    • Different Human System Profiles of Target
    • Cell-based Expression Variations of Target
    • Chemical Structure based Activity Landscape of Target
    • Drug Property Profile of Target
    • Co-Targets of Target
    • Poor or Non Binders of Target
    • Targets of Patented Therapeutic Agents
    • Target Interacting Proteins
    • Target Regulators - MicroRNA
    • Target Regulators - Transcription Factor
    • Targeted Antigens of CAR-T Cell Therapy
    • Target Combination
  • Drug Group
    • Approved Drugs
    • Clinical Trial Drugs
    • Interactions between Drug and Microbiota
    • Prodrugs
    • Patented Therapeutic Agents
    • Small Molecule Agents of Immunotherapy Targets
    • Multi-target Agents
    • Nature-derived Drugs
  • Patient Data
    • Drug Resistance Mutations
    • Target Expression Profiles
  • Download
    • TTD Full Data Download
    • COVID-19 Data Download

Drug Information

Drug General Information
Drug ID
D0JA3Y
Former ID
DCL001212
Drug Name
MEDI-578
Indication Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] Phase 1 [551134]
Target and Pathway
Target(s) Beta-nerve growth factor Target Info Modulator
KEGG Pathway MAPK signaling pathway
Ras signaling pathway
Rap1 signaling pathway
PI3K-Akt signaling pathway
Apoptosis
Neurotrophin signaling pathway
Inflammatory mediator regulation of TRP channels
Pathway Interaction Database SHP2 signaling
p75(NTR)-mediated signaling
Neurotrophic factor-mediated Trk receptor signaling
Trk receptor signaling mediated by PI3K and PLC-gamma
Reactome Frs2-mediated activation
ARMS-mediated activation
NRAGE signals death through JNK
p75NTR negatively regulates cell cycle via SC1
PI3K/AKT activation
NADE modulates death signalling
NRIF signals cell death from the nucleus
p75NTR recruits signalling complexes
NF-kB is activated and signals survival
Axonal growth stimulation
WikiPathways SIDS Susceptibility Pathways
MAPK Signaling Pathway
BDNF signaling pathway
Signalling by NGF
NGF signalling via TRKA from the plasma membrane
References
Ref 551134Clinical pipeline report, company report or official report of MedImmune (2011).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Cite TTD

Y. Zhou, Y. T. Zhang, D. H. Zhao, X. Y. Yu, X. Y. Shen, Y. Zhou, S. S. Wang , Y. Q. Qiu*, Y. Z. Chen* & F. Zhu* . TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Research. 52(D1): 1465-1477 (2024). PMID: 37713619

About TTD

A database to provide information about the known and explored therapeutic protein and nucleic acid targets, the targeted disease, pathway information and the corresponding drugs directed at each of these targets. All information provided are fully referenced.
All rights are reserved.

Correspondence

Prof. Feng ZHU 
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. 
Prof. Yuzong CHEN 
Department of Pharmacy, National University of Singapore, Singapore.